Metropolitan Life Insurance Company (MetLife)’s Athenex, Inc. Common Stock ATNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-432
Closed -$26K 2858
2021
Q3
$26K Sell
432
-872
-67% -$63.5K ﹤0.01% 2812
2021
Q2
$121K Buy
1,304
+968
+288% +$88K ﹤0.01% 2501
2021
Q1
$28.9K Sell
336
-691
-67% -$132K ﹤0.01% 2558
2020
Q4
$227K Sell
1,027
-48
-4% -$11.8K ﹤0.01% 1847
2020
Q3
$260K Sell
1,075
-50
-4% -$12K ﹤0.01% 1615
2020
Q2
$310K Sell
1,125
-7
-0.6% -$1.48K 0.01% 1524
2020
Q1
$175K Buy
1,132
+52
+5% +$13.1K ﹤0.01% 1669
2019
Q4
$330K Sell
1,080
-50
-4% -$13.2K 0.01% 1582
2019
Q3
$275K Buy
1,130
+357
+46% +$117K ﹤0.01% 1656
2019
Q2
$306K Buy
773
+61
+9% +$16.9K 0.01% 1606
2019
Q1
$175K Hold
712
﹤0.01% 1985
2018
Q4
$181K Hold
712
﹤0.01% 1894
2018
Q3
$221K Hold
712
﹤0.01% 1937
2018
Q2
$266K Buy
+712
New +$244K ﹤0.01% 1753

Other funds holding ATNX

Metropolitan Life Insurance Company (MetLife)'s ATNX Position: Q4 2021 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Athenex, Inc. Common Stock (ATNX) in Q4 2021, closing a stake of 432 shares — an estimated $26K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in ATNX in Q2 2018 and held it in 14 quarters. The position peaked at $330K in Q4 2019. 103 funds tracked by Wall St. Rank hold ATNX as of Q4 2021.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Athenex, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 432 Athenex, Inc. Common Stock shares in Q4 2021, an estimated $26K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Athenex, Inc. Common Stock in Q2 2018 and held it in 14 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Athenex, Inc. Common Stock position peaked at $330K in Q4 2019.
  • 103 funds tracked by Wall St. Rank held Athenex, Inc. Common Stock as of Q4 2021.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2021, filed 15 Feb 2022.